유럽 ​​조직 재생 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

조직 재생은 병들거나 손상된 조직을 회복하거나 고치기 위해 재생하거나 대체하는 과정을 말합니다. 선천적 장애, 이상, 질병으로 인한 조직 손상은 모두 조직 재생의 필요성을 증가시킵니다. 조직 공학은 손상된 조직의 기능을 보존, 회복 및 개선하는 기술입니다. 신장과 같은 손상된 장기를 재건함으로써 조직 재생 과정은 환자의 기대 수명을 향상시킵니다. 재생 의학은 현재의 장기 기증자 부족을 종식시킬 수 있습니다. 예를 들어, 조직 공학 피부는 다리와 발에 영향을 미치는 피부 교체, 화상, 상처 및 궤양에 유익합니다.

Data Bridge Market Research는 조직 재생 시장이 2021년에 129억 8천만 달러였고, 2029년까지 381억 1천만 달러로 급증할 것으로 분석했으며, 2022년에서 2029년까지의 예측 기간 동안 14.5%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

손상되거나 병든 조직을 복구하거나 교체하여 고치거나 수리하는 것을 조직 재생이라고 합니다. 선천적 장애, 이상, 질병으로 인한 조직 손상은 모두 조직 재생의 필요성을 증가시킵니다. 조직 공학은 손상된 조직의 기능을 보존, 복구 및 개선하는 기술입니다. 조직 재생 과정은 손상된 장기를 재건하여 환자의 기대 수명을 향상시킵니다.

보고 범위 및 시장 세분화

Tissue Regeneration Market Dynamics

Drivers

• Increasing frequency of chronic diseases and the need for surgeries

The market is expected to grow during the projected period due to the increased use of biomarkers for illness detection and the rapid development of procedures such as stem cell technologies and gene therapy, among others. Increased responsiveness of the benefits and availability of equipment among doctors and convicts will also help to boost the tissue regeneration market's growth pace. The rising demand for tailored treatments will be a significant market driver, boosting the demand for tissue regeneration even more. In addition, changing lifestyles and eating habits will increase the risk of chronic diseases, resulting in a faster market growth rate.

• Rising of the functions of 3D printing in tissue regeneration

 In the projected term, advancements in biomaterials, nanotechnology, cell treatments, and medication delivery are expected to boost the tissue regeneration market's growth. Government regulations, repayment concerns, particularly in emerging economies, in developing countries, are most likely to drive the tissue regeneration market's expansion.

• Increase in popularity of tissue regeneration technology

The number of procedures for regeneration is on the rise. The use of tissue-engineered vascular grafts in the treatment and surgery of cardiovascular disease is being researched at the pre-clinical stage. Progress is currently being made in developing tissue-engineered bladders outside of the patient's body and successful transplantation.

Opportunities

During the forecast period, growth in demand for technologies such as 3D printing in tissue regeneration and an increase in R&D activities will provide new opportunities for the tissue regeneration market. Furthermore, government grants and investments and innovations in biomaterials, nanotechnology, cell treatments, and medication delivery are likely to improve the market's positive potential in the future.

Restraints/Challenges

However, the Europe market is likely to be hampered by tight government regulations, high treatment costs, and difficulty obtaining reimbursements and coverage for these therapies. This technique is costly (especially long-term choices), may have adverse effects on first-time patients, may lead to complications and even infections/ruptures in the early stages.

This tissue regeneration market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue regeneration market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Tissue Regeneration Market

The pandemic of COVID-19 has had a significant impact on the healthcare industry. Since the COVID 19 pandemic, clinical tissue engineering research has been made unavailable, and non-COVID 19 clinical trials have been reduced. Meanwhile, a number of pharmaceutical and biotech companies have redirected their focus to COVID-19 therapy medications and vaccines. Furthermore, a significant decline in cell and tissue donation programs has constrained the worldwide tissue engineering market. As a result, delays and disturbances in clinical research and cancellations or delays in tissue replacement and reconstructive treatments stymie the Europe tissue engineering market's growth.

Recent Development

 In 2020, the United States Department of Health announced the "New Vision" project, aiming to put regenerative medicine and stem cell therapy at the forefront of healthcare.

In April 2020, Tissue Regeneration Technologies (TRT) announced a significant addition to our patent family, which could help in the fight against the Coronavirus. This patent uses the well-understood processes of unfocused shockwaves to combat this deadly pathogen.

Europe Tissue Regeneration Market Scope

The tissue regeneration market is segmented on the basis of component, raw material, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Components

• Cell Therapy
• Stem Cell Therapy
• Stem Cell Sources
• Existing and Development-stage Stem Cell Products
• Tissue Vascularization
• Cell Culturing
• Small Molecules and Biologics
• Others

Raw Material

• Synthetic
• Genetically Modified
• Biological

Application

• Cardiovascular Disorders
• Oncology
• Dermatology
• Neurology
• Ophthalmology
• Others

End-User

• Hospitals
• Clinics
• Ambulatory Centers
• Laboratories

Tissue Regeneration Market Regional Analysis/Insights

The tissue regeneration market is analyzed and market size insights and trends are provided by country, component, raw material, application and end-user as referenced above.

The countries covered in the tissue regeneration market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

During the forecast period, Europe is expected to account for most of the Europe tissue regeneration market. During the forecast period, new product releases, prominent market players focused on research and development, and an rise in the frequency of chronic diseases are expected to boost the tissue regeneration market in the area.

Due to rise in geriatric population, the tissue regeneration market in Asia Pacific is likely to rise at a quick rate over the forecast period. Furthermore, government attempts to expand healthcare infrastructure are expected to boost the region's industry.

 The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The tissue regeneration market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue regeneration market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue regeneration market. The data is available for historic period 2010-2020.

Competitive Landscape and Tissue Regeneration Market Share Analysis

The tissue regeneration market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue regeneration market.

Some of the major players operating in the tissue regeneration market are:

• Arteriocyte Medical Systems Inc. (U.S.)
• Athersys Inc. (Ohio)
• Cerapedics Inc. (U.S.)
• Co. Don AG (Germany)
• Cook Medical Inc. (U.S.)
• U.S. Stem Cell Inc. (U.S.)
• Cytori Therapeutics, Inc. (U.S.A)
• Cerapedicsm, Inc. (U.S.)
• Organogenesis, Inc. (U.S.)
• Wright Medical Group N.V. (Netherlands)
• Zimmer Biomet (US)
• ACell, Inc. (U.S.)
• Tissue Regenix (U.S.)

SKU-48002